Inventor · disambiguated record
Kamal D. Puri
Also filed as: PURI KAMAL D · PURI KAMAL DEEP
14 granted patents·13 pending applications·247 citations·filing 2004–2024
94Inventor score
Top patents by PatentIndex Score
27 records- 0198US8980901B25-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Mar 17, 2015·39 cites·21 claims
- 0298USRE44599EQuinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2012·Granted Nov 12, 2013·44 cites·6 claims
- 0397US8779131B26-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Jul 15, 2014·30 cites·10 claims
- 0497US8586597B26-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2012·Granted Nov 19, 2013·36 cites·6 claims
- 0596US8993583B25-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Mar 31, 2015·22 cites·13 claims
- 0696USRE44638EQuinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaFOWLER KERRY W·Filed 2005·Granted Dec 10, 2013·46 cites·2 claims
- 0795US9149477B25-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2014·Granted Oct 6, 2015·17 cites·12 claims
- 0891US11034770B2Immunomodulatory antibodies and methods of use thereofONCORESPONSE INC·Filed 2020·Granted Jun 15, 2021·3 cites·11 claims
- 0991US10336756B2(S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2015·Granted Jul 2, 2019·5 cites·2 claims
- 1090US11827715B2Human CD163 antibodies and uses thereofONCORESPONSE INC·Filed 2021·Granted Nov 28, 2023·2 cites·29 claims
- 1188US11634501B2Immunomodulatory antibodies and methods of use thereofONCORESPONSE INC·Filed 2020·Granted Apr 25, 2023·2 cites·25 claims
- 1281US12195549B2Immunomodulatory antibodies and methods of use thereofONCORESPONSE INC·Filed 2023·Granted Jan 14, 2025·0 cites·14 claims
- 1381US2024239914A1Human cd163 antibodies and uses thereofONCORESPONSE INC·Filed 2023·Application pending·0 cites
- 1478US10906907B2Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereofICOS CORP·Filed 2019·Granted Feb 2, 2021·0 cites·9 claims
- 1577US2021332047A1Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2020·Application pending·0 cites
- 1665US2025002577A1Lilrb2/1 antibody products and methodsONCORESPONSE INC·Filed 2024·Application pending·0 cites
- 1764US2023181732A1Combinations of immunotherapies and uses thereofONCORESPONSE INC·Filed 2022·Application pending·0 cites
- 1864US2024132589A1Lilrb2 antibody products and methodsONCORESPONSE INC·Filed 2023·Application pending·0 cites
- 1963US8546409B2Methods of treatment for solid tumorsPURI KAMAL D·Filed 2010·Granted Oct 1, 2013·1 cites·25 claims
- 2058US2005043239A1Methods of inhibiting immune responses stimulated by an endogenous factorFiled 2004·Application pending·0 cites
- 2158US2024084029A1Use of immunomodulatory antibodies to treat fibrotic diseasesONCORESPONSE INC·Filed 2022·Application pending·0 cites
- 2257US2010029693A1Novel pi3k delta inhibitors and methods of use thereofDOUANGPANYA JASON·Filed 2009·Application pending·0 cites
- 2355US2024092926A1Immunomodulatory antibodies and uses thereofONCORESPONSE INC·Filed 2022·Application pending·0 cites
- 2451US2005054614A1Methods of inhibiting leukocyte accumulationFiled 2004·Application pending·0 cites
- 2548US2013344138A1Methods of treatment for solid tumorsGILEAD CALISTOGA LLC·Filed 2013·Application pending·0 cites
- 2648US2008287469A1Phosphoinositide 3-Kinase Inhibitors for Inhibiting Leukocyte AccumulationDIACOVO THOMAS G·Filed 2006·Application pending·0 cites
- 2741US2014235643A1Novel quinoxaline inhibitors of pi3kGILEAD CALISTOGA LLC·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kamal D. Puri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →